| IL-6–based mortality risk model for hospitalized patients with COVID-19 R Laguna-Goya, A Utrero-Rico, P Talayero, M Lasa-Lazaro, ... Journal of Allergy and Clinical Immunology 146 (4), 799-807. e9, 2020 | 204 | 2020 |
| An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad antitumor activity in humanized murine cancer models without toxicity M Compte, SL Harwood, A Erce-Llamazares, A Tapia-Galisteo, E Romero, ... Clinical Cancer Research 27 (11), 3167-3177, 2021 | 21 | 2021 |
| Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies B Blanco, Á Ramírez-Fernández, L Alvarez-Vallina Frontiers in Immunology 11, 1792, 2020 | 18 | 2020 |
| Overcoming CAR-mediated CD19 downmodulation and leukemia relapse with T lymphocytes secreting anti-CD19 T-cell Engagers B Blanco, Á Ramírez-Fernández, C Bueno, L Argemí-Muntadas, ... Cancer immunology research 10 (4), 498-511, 2022 | 15 | 2022 |
| A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response L Rubio-Pérez, R Lázaro-Gorines, SL Harwood, M Compte, R Navarro, ... Oncoimmunology 12 (1), 2205336, 2023 | 9 | 2023 |
| Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies Á Ramírez-Fernández, Ó Aguilar-Sopeña, L Díez-Alonso, ... Oncoimmunology 11 (1), 2054106, 2022 | 9 | 2022 |
| Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo L Díez-Alonso, A Falgas, J Arroyo-Ródenas, PA Romencín, A Martínez, ... Science translational medicine 16 (734), eadg7962, 2024 | 3 | 2024 |
| Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells. J Arroyo-Rodenas, L Díez-Alonso, A Falgas, A Martinez-Moreno, ... Journal of Clinical Oncology 42 (16_suppl), 2550-2550, 2024 | | 2024 |
| CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts A Jiménez-Reinoso, M Molero-Abraham, C Cirauqui, B Blanco, ... bioRxiv, 2024.05. 27.596077, 2024 | | 2024 |
| Inmunoterapia" STAb" para el tratamiento de neoplasias hematológicas Á Ramírez Fernández Universidad Complutense de Madrid, 2023 | | 2023 |
| Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers B Blanco, Á Ramírez-Fernández, C Bueno, L Argemí-Muntadas, ... Cancer Immunology Research 10 (4), 498-511, 2022 | | 2022 |
| TESIS DOCTORAL Inmunoterapia" STAb" para el tratamiento de neoplasias hematológicas ÁR Fernández Universidad Complutense de Madrid, 2022 | | 2022 |
